These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6562340)

  • 1. [How the human body protects itself against the influenza virus].
    Shvartsman IaS
    Med Sestra; 1984 Mar; 43(3):13-6. PubMed ID: 6562340
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hamster as a model for the study of immunity to influenza virus infection.
    Jennings R; Potter CW
    Fed Proc; 1978 May; 37(7):2072-3. PubMed ID: 640018
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the host on the phase transformations of an influenza virus population].
    Skripchenko GS; Vlasova AG; Rybakova TM
    Vestn Akad Med Nauk SSSR; 1983; (5):28-34. PubMed ID: 6868801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP; Bichurina MA; Rozaeva NR
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies against influenza--individual and group immunity (author's transl)].
    Farník J; Bruj J; Skocil V
    Cesk Epidemiol Mikrobiol Imunol; 1980 Jan; 29(1):33-8. PubMed ID: 6445784
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.
    Nguyen HH; Moldoveanu Z; Novak MJ; van Ginkel FW; Ban E; Kiyono H; McGhee JR; Mestecky J
    Virology; 1999 Feb; 254(1):50-60. PubMed ID: 9927573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription.
    Mukhtar MM; Li S; Li W; Wan T; Mu Y; Wei W; Kang L; Rasool ST; Xiao Y; Zhu Y; Wu J
    Int J Biochem Cell Biol; 2009 Mar; 41(3):554-60. PubMed ID: 18687409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protection of the elderly against influenza (a review of the literature)].
    Rudenko LG; Zykov MP
    Vrach Delo; 1981 Dec; (12):8-11. PubMed ID: 6895807
    [No Abstract]   [Full Text] [Related]  

  • 14. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
    Khanlou H; Sanchez S; Babaie M; Chien C; Hamwi G; Ricaurte JC; Stein T; Bhatti L; Denouden P; Farthing C
    Arch Intern Med; 2006 Jul; 166(13):1417. PubMed ID: 16832008
    [No Abstract]   [Full Text] [Related]  

  • 15. [Universal influenza vaccine still far in the future].
    Rimmelzwaan GF; Osterhaus AD
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2305-7. PubMed ID: 10589217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A
    J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus.
    Saha S; Yoshida S; Ohba K; Matsui K; Matsuda T; Takeshita F; Umeda K; Tamura Y; Okuda K; Klinman D; Xin KQ; Okuda K
    Virology; 2006 Oct; 354(1):48-57. PubMed ID: 16945400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avian influenza. 'Pandemic vaccine' appears to protect only at high doses.
    Enserink M
    Science; 2005 Aug; 309(5737):996. PubMed ID: 16099954
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 20. One step closer to universal influenza epitopes.
    Li OT; Poon LL
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):687-90. PubMed ID: 19681695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.